A. , J. Larsson, L. Klaar, S. Holmberg, L. Nilsson et al., Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF, Ann. Oncol, vol.16, pp.743-748, 2005.

B. , Z. , S. , H. Bakkar, A. A. Wallerand et al., Effect of high dimension: By an example of a two sample problem, FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder, pp.311-329, 1996.

D. M. Barnes, Cyclin D1 in mammary carcinoma, The Journal of Pathology, vol.9, issue.3, pp.267-269, 1997.
DOI : 10.1002/(SICI)1096-9896(199703)181:3<267::AID-PATH783>3.0.CO;2-X

B. , Y. , H. , Y. Chen, S. X. et al., Controlling the false discovery rate: A practical and powerful approach to multiple testing A two-sample test for high-dimensional data with applications to gene-set testing. Ann. Statist Cell cycle genes and ovarian cancer susceptibility: A tagSNP analysis, J. Roy. Statist. Soc. Ser. B Br. J. Cancer, vol.57, issue.101, pp.289-300, 1995.

D. Gupta, S. , P. , and M. D. , Power of the noncentral F test: Effect of additional variates on Hotelling's T 2 -test, J. Amer. Statist. Assoc, vol.69, pp.174-180, 1974.

D. , S. Van-der, M. J. Laan, S. E. Dunn, F. W. Kari et al., Multiple Testing Procedures with Applications to Genomics Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice, Cancer Res, vol.57, pp.4667-4672, 1997.

E. , L. Kela, I. Getz, G. Givol, D. et al., Outcome signature genes in breast cancer: Is there a unique set, Bioinformatics, vol.21, pp.171-178, 2005.

E. , V. P. Lax, I. , S. , and J. , Cellular signaling by fibroblast growth factor receptors, Cytokine Growth Factor Rev, vol.16, pp.139-149, 2005.

E. , L. C. Providence, R. Fan, J. , L. et al., Partial Differential Equations Amer Test of significance when data are curves, p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines, pp.1007-1021, 1998.

G. , M. C. Detre, S. Johnston, S. Mohsin, S. K. Shou et al., Molecular changes in tamoxifenresistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogenactivated protein kinase, J. Clin. Oncol, vol.23, pp.2469-2476, 2005.

H. , D. K. Vandergheynst, P. , G. , and R. , Wavelets on graphs via spectral graph theory, 2009.
URL : https://hal.archives-ouvertes.fr/inria-00541855

H. , A. C. Gestraud, P. , V. , and J. P. , The influence of feature selection methods on accuracy, stability and interpretability of molecular signatures, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00559580

H. , A. C. Jacob, L. , V. , and J. P. , Increasing stability and interpretability of gene expression signatures, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00448395

H. , S. López-knowles, E. Lloreta, J. Kogevinas, M. Jaramillo et al., FGFR3 and Tp53 mutations in T1G3 transitional bladder carcinomas: Independent distribution and lack of association with prognosis, Clin. Cancer Res, vol.11, pp.5444-5450, 2005.

H. , M. H. Beyer, A. R. Cui, Y. Weiss, H. Anderson et al., Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells, Mol. Cancer Ther, vol.5, pp.3023-3031, 2006.

H. , T. Wang, H. Kingsley, E. A. Risbridger, G. P. et al., Molecular profiling of bladder cancer: Involvement of the TGF-beta pathway in bladder cancer progression, Cancer Lett, vol.265, pp.27-38, 2008.

I. , T. Ozier, O. Schwikowski, B. , S. et al., Discovering regulatory and signalling circuits in molecular interaction networks, pp.233-240, 2002.

J. , L. Neuvial, P. , D. , and S. , Supplement A to More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011.

J. , L. Neuvial, P. , D. , and S. , Supplement B to " More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011.

J. , L. Neuvial, P. , D. , and S. , Supplement C to " More power via graphstructured tests for differential expression of gene networks, pp.10-1214, 2011.

J. , L. Obozinski, G. , V. , and J. , Group lasso with overlap and graph lasso, ICML'09: Proceedings of the 26th Annual International Conference on Machine Learning, pp.433-440, 2009.

J. , R. Audibert, J. Y. , B. , and F. , Structured variable selection with sparsityinducing norms, p.WILLOW?INRIA, 2009.
URL : https://hal.archives-ouvertes.fr/inria-00377732

J. , N. Bentley, J. Wang, L. Newell, D. R. Robson et al., Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells, Br. J. Cancer, vol.102, pp.342-350, 2010.

A. H. Land, D. , A. G. Levidou, G. Saetta, A. A. Karlou et al., An Automatic Method of Solving Discrete Programming Problems, Econometrica, vol.28, issue.3, pp.497-520, 1960.
DOI : 10.2307/1910129

L. , S. Haibe-kains, B. Desmedt, C. Wirapati, P. Lallemand et al., Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen, BMC Genomics, vol.9, p.239, 2008.

L. , I. , S. , T. Lopes, M. E. Jacob et al., Replicated microarray data A more powerful two-sample test in high dimensions using random projection, Statist. Sinica, vol.12, pp.31-46, 2002.

L. , M. C. Mcclellan, A. Siewit, C. , K. et al., Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance, Mol. Cancer Res, vol.8, pp.343-352, 2010.

L. , Y. Liu, P. Xiao, P. , D. et al., Hotelling's T 2 multivariate profiling for detecting differential expression in microarrays, Bioinformatics, vol.21, pp.3105-3113, 2005.

L. , C. D. Philpott, A. Metcalfe, J. C. Thompson, A. M. Hughes-davies et al., Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer, Cancer Res, vol.61, pp.482-485, 2001.

M. , L. M. Kirkegaard, T. Edwards, J. Tovey, S. Cameron et al., Ras/Raf-1/MAPK pathway mediates response to tamoxifen but not chemotherapy in breast cancer patients, Clin. Cancer Res, vol.15, pp.1487-1495, 2009.

M. , A. P. Pagliarulo, V. , Y. , D. Waldman et al., Generation of a concise gene panel for outcome prediction in urinary bladder cancer, J. Clin. Oncol, vol.27, pp.3929-3937, 2009.

N. , S. Critchley-thorne, R. Lee, P. , H. et al., Gene expression network analysis and applications to immunology, Bioinformatics, vol.23, p.850, 2007.

O. , G. Jacob, L. , V. , and J. P. , Group Lasso with overlaps: The latent group Lasso approach, 2011.
URL : https://hal.archives-ouvertes.fr/inria-00628498

P. , S. Shak, S. Tang, G. Kim, C. Baker et al., A multigene assay to predict recurrence of tamoxifentreated , node-negative breast cancer, N. Engl. J. Med, vol.351, pp.2817-2826, 2004.

P. , C. M. Sørlie, T. Eisen, M. B. Van-de-rijn, M. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000.

R. , E. A. Boyce, R. W. El-rehim, D. A. Kurien, T. Green et al., Expression of mucins and MUC6) and their prognostic significance in human breast cancer, Mod. Pathol, vol.18, pp.5-1295, 2005.

R. , F. Zinovyev, A. Dutreix, M. Barillot, E. et al., Classification of microarray data using gene networks, BMC Bioinformatics, vol.8, p.35, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00433577

R. , D. Sarkar, S. , F. , and Q. , Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells, Front. Biosci, vol.11, pp.889-898, 2006.

S. , M. Socci, N. D. Lozano, J. Saint, F. et al., Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays, J. Clin. Oncol, vol.24, pp.778-789, 2006.

S. , T. Blitzer, J. Talukdar, P. , P. et al., Regularized learning with networks of features, Neural Information Processing Systems, 2009.

S. , C. H. Ohneseit, P. F. Gonzalez-zulueta, M. Esrig, D. Miyao et al., Two molecular pathways to transitional cell carcinoma of the bladder, Cancer Res, vol.54, pp.784-788, 1994.

S. Srinivasan, S. Zafar, Z. Nawaz, L. , and B. W. , Transcriptional regulation of MUC2 by estrogen, Gastrointestinal Cancers Symposium, 2007.

S. , M. S. Srivastava, M. S. , D. , M. Stewart et al., A test for the mean vector with fewer observations than the dimension under nonnormality A test for the mean vector with fewer observations than the dimension. J. Multivariate Anal Matrix Perturbation Theory Regional copy number-independent deregulation of transcription in cancer, J. Multivariate Anal. Nat. Genet, vol.100, issue.38, pp.518-532, 1990.

A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, pp.15545-15550, 2005.
DOI : 10.1073/pnas.0506580102

T. , Y. C. , S. , T. P. Turner, N. Pearson et al., On gene ranking using replicated microarray time course data FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer, Biometrics Cancer Res, vol.65, issue.70, pp.40-51, 2009.

B. W. Van-rhijn, T. H. Van-der-kwast, A. N. Vis, W. J. Kirkels, E. R. Boevé et al., FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma, Cancer Research, vol.64, issue.6, pp.1911-1914, 2004.
DOI : 10.1158/0008-5472.CAN-03-2421

V. , F. Upfal, E. , R. , and B. J. , Algorithms for detecting significantly mutated pathways in cancer, Lecture Notes in Computer Science, vol.6044, pp.506-521, 2010.

V. , C. Benz, S. Sanborn, Z. Earl, D. Szeto et al., Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, ISMB, 2010.

W. , M. D. Mcguckin, M. A. Devine, P. L. Hohn, B. G. et al., Expression of MUC2 epithelial mucin in breast carcinoma, J. Clin. Pathol, vol.46, pp.922-925, 1993.

W. , W. Pew, T. Zou, M. Pang, D. et al., Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival, J. Biol. Chem, vol.280, pp.4117-4124, 2005.